Literature DB >> 1195780

Mediastinal granuloma.

C V Strimlan, D E Dines, W S Payne.   

Abstract

In a group of 47 patients with mediastinal granulomas, the most common clinical symptoms were cough, chest pain, dysphagia, hemoptysis, and dyspnea. The main laboratory findings were right paratracheal or hilar mass on chest roentgenogram, positive histoplasmin skin test, and caseating granuloma on histopathologic examination. Complications included fibrosing mediastinitis with superior vena cava obstruction, esophageal compression, and major upper airway compression. Treatment was usually surgical resection or evacuation of caseous contents. The prognosis in most patients with mediastinal granulomas appears to be good--long-term survival with minimal or no disability.

Entities:  

Mesh:

Year:  1975        PMID: 1195780

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  6 in total

1.  Radiographic findings in patients with esophageal involvement by mediastinal granuloma.

Authors:  R L MacCarty; R J Dukes; C V Strimlan; D E Dines; W S Payne
Journal:  Gastrointest Radiol       Date:  1979-01-30

2.  Malignant histiocytosis. Clinical findings and therapy.

Authors:  D Huhn; P Meister; W Wilmanns
Journal:  Klin Wochenschr       Date:  1980-01-02

3.  Respiratory disease in Canadian First Nations and Inuit children.

Authors:  Thomas Kovesi
Journal:  Paediatr Child Health       Date:  2012-08       Impact factor: 2.253

Review 4.  [Treatment of chronic mediastinitis].

Authors:  R Scheubel
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

5.  Sclerosing mediastinitis: a report on 18 cases.

Authors:  T M Mole; J Glover; M N Sheppard
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

6.  Clinical Manifestations of Fibrosing Mediastinitis in Chinese Patients.

Authors:  Yan Hu; Jian-Xing Qiu; Ji-Ping Liao; Hong Zhang; Zhe Jin; Guang-Fa Wang
Journal:  Chin Med J (Engl)       Date:  2016-11-20       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.